Welcome to our dedicated page for ReposiTrak SEC filings (Ticker: TRAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
ReposiTrak filings document a Nevada operating company that provides SaaS-based traceability, compliance, risk management, and supply chain applications for retailers, wholesalers, suppliers, and food manufacturers. Its Form 8-K disclosures record quarterly results and earnings-call materials, cash dividend declarations, share repurchase authorizations, and material commercial or financing agreements involving its subsidiary PC Group.
Governance filings cover director appointments, committee assignments, annual meeting voting results, executive compensation advisory votes, and common-stock matters. The disclosures also describe the company's product families, public-company governance framework, capital allocation actions, and regulatory context for food safety and supply chain compliance.
A shareholder of TRAK has filed a notice of proposed sale of common stock under Rule 144. The filing covers 1,641 common shares, with an aggregate market value of $21,658.08, to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 12/22/2025. The shares are part of a total of 18,288,455 shares of this class outstanding. The seller originally acquired these shares on 09/19/2013 in an open market purchase from the issuer, paid in cash.
ReposiTrak, Inc. disclosed that its board has declared a quarterly cash dividend of $0.02 per share, which equates to $0.08 per share on an annual basis, on its common stock. The dividend is scheduled to be paid on or about February 13, 2026 to stockholders who are on record as of December 31, 2025. The company furnished this information through a press release attached as an exhibit, emphasizing that it is being provided for informational purposes and is not treated as filed for liability purposes under securities laws.
ReposiTrak, Inc. reported that CEO, director and 10% owner Randall K. Fields sold 7,500 shares of common stock on 12/16/2025 at a weighted average price of $13.2977, coded as an "S" sale transaction.
The sale occurred automatically under a Rule 10b5-1 trading plan adopted by Fields in his capacity as trustee of the 2022 RK Fields Charitable Remainder Unitrust, the managing member of RK Fields Charitable 2022, LLC, and was established to help meet some of his charitable commitments.
After this transaction, Fields beneficially owned 3,483,955 shares of common stock directly, 175,000 shares of common stock indirectly through RK Fields Charitable 2022, LLC, 615,260 common and 229,262 Series B preferred shares through Riverview Financial Corp, 30,667 common and 5,320 Series B preferred shares through his spouse, and 333,643 common shares through Fields Management, Inc.
ReposiTrak, Inc. chairman and chief executive officer Randall K. Fields, who is also a director and 10% owner, reported a series of automatic sales of ReposiTrak common stock made by RK Fields Charitable 2022, LLC under a pre-arranged Rule 10b5-1 trading plan.
The LLC sold 4,453 shares on 12/03/2025 at a weighted average price of $13.4023, 3,000 shares on 12/08/2025 at $13.7212, 2,500 shares on 12/09/2025 at $13.6363, and 2,000 shares on 12/10/2025 at $13.6991, all coded as open-market sales. The prices reflect multiple trades within disclosed price ranges on each day.
Following these transactions, RK Fields Charitable 2022, LLC held 182,500 shares of ReposiTrak common stock. Fields also reported additional holdings, including 3,483,955 shares of common stock held directly and various indirect positions through entities such as Riverview Financial Corp., his spouse, and Fields Management, Inc., as well as related preferred stock holdings.
ReposiTrak, Inc. announced that its Board of Directors has approved a new Rule 10b5-1 share repurchase program authorizing the company to buy back up to $2 million of its common stock. This automated plan operates under the company’s previously approved overall share repurchase authorization of up to $21 million, of which $7.6 million remained available to repurchase as of December 1, 2025. The update was disclosed in a current report and accompanied by a press release filed as an exhibit.
ReposiTrak, Inc.’s chief executive officer, director and 10% owner Randall K. Fields reported small open-market sales of the company’s common stock. On 12/01/2025, an affiliated entity, RK Fields Charitable 2022, LLC, sold 2,000 shares at a weighted average price of $13.3836. On 12/02/2025, the same entity sold 1,047 shares at a weighted average price of $13.0045. Both transactions occurred under a pre-arranged Rule 10b5-1 trading plan designed to help Fields meet charitable commitments through the 2022 RK Fields Charitable Remainder Unitrust. After these sales, he reports indirect ownership of 194,453 shares through RK Fields Charitable 2022, LLC, along with additional direct and indirect holdings through other entities and his spouse.
ReposiTrak, Inc. (TRAK) CEO and 10% owner Randall K. Fields reported multiple stock movements involving company shares. On 11/24/2025, 200,000 shares of common stock were transferred out of his direct ownership and 200,000 shares were received by RK Fields Charitable 2022, LLC as a gift at a reported price of $0. The same day, that charitable entity sold 1,000 shares at a weighted average price of $13.1169, followed by an additional sale of 6,500 shares on 11/25/2025 at a weighted average price of $13.1791.
The sales were executed automatically under a Rule 10b5-1 trading plan established to help meet charitable commitments. Following these transactions, Fields reported continued indirect holdings through several entities, including RK Fields Charitable 2022, LLC, Riverview Financial Corp., his spouse, and Fields Management, Inc., as well as direct ownership of ReposiTrak common stock.
ReposiTrak, Inc. (TRAK) insider Randall K. Fields, who is a director, 10% owner and chief executive officer, reported automatic sales of common stock by an affiliated charitable entity. On 11/17/2025, 11/19/2025, and 11/20/2025, RK Fields Charitable 2022, LLC sold 1,000, 4,500 and 2,000 shares of ReposiTrak common stock, respectively, at weighted average prices of $14.807, $14.0109 and $13.4659. The filing states these transactions were executed under a pre-established Rule 10b5-1 trading plan designed to help Fields meet charitable commitments. Following these trades, Fields continues to report significant holdings, including 3,683,955 shares of common stock held directly, plus additional common and Series B preferred shares held indirectly through entities and a spouse.
ReposiTrak, Inc. reported the results of its Annual Meeting of Stockholders held on November 19, 2025. Stockholders elected four directors — Randall K. Fields, Robert W. Allen, Ronald C. Hodge and Peter J. Larkin — each by a plurality of votes cast, with support of more than 9.4 million votes for each nominee.
Stockholders also approved, on a non-binding advisory basis, the executive compensation program, with approximately 9.4 million votes cast in favor versus smaller amounts against or abstaining. In a separate advisory vote on how often to hold future say-on-pay votes, the largest number of votes, about 7.3 million, supported holding the vote every three years, and the Board determined that frequency going forward.
Additionally, stockholders ratified the appointment of Haynie & Company as the Company’s independent registered public accounting firm. These outcomes confirm continuity in the Company’s board composition, executive pay approach, and audit arrangements.
ReposiTrak, Inc. reported that it has released its financial results for the fiscal quarter ended September 30, 2025. The company issued a press release and held an earnings call on November 13, 2025 to discuss these results. The press release and the full earnings call transcript are provided as exhibits to this report, giving investors access to detailed quarterly performance information and management’s commentary. The common stock of ReposiTrak continues to trade on the New York Stock Exchange under the symbol TRAK.